EA
ZBH icon

Emerald Acquisition’s Zimmer Biomet ZBH Stock Holding History

Emerald Acquisition’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$128M Sell
1,013,574
-113,598
-10% -$14M 0.25% 81
2016
Q2 		$132M Buy
+1,127,172
New +$128M 0.23% 92

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emerald Acquisition's ZBH Position: Q3 2016 in Review

Emerald Acquisition reduced its Zimmer Biomet (ZBH) stake by 10% in Q3 2016, selling an estimated $14M and leaving 1,013,574 shares worth $128M. The position accounts for 0.25% of the portfolio, ranked #81.

Emerald Acquisition first reported a position in ZBH in Q2 2016 and has held it in 2 quarters since. The position peaked at $132M in Q2 2016. 808 funds tracked by Wall St. Rank hold ZBH as of Q3 2016.

  • Emerald Acquisition held 1,013,574 shares of Zimmer Biomet worth $128M as of Q3 2016.
  • Emerald Acquisition sold 113,598 Zimmer Biomet shares in Q3 2016, an estimated $14M.
  • Zimmer Biomet made up 0.25% of Emerald Acquisition's portfolio in Q3 2016, its #81 holding.
  • Emerald Acquisition first reported a position in Zimmer Biomet in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Zimmer Biomet position peaked at $132M in Q2 2016.
  • 808 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.